Highlights
-
Today’s Research Article: PRP beats PT in restoring shoulder function—lasting results without surgery.
-
Questions from the Field: Not all PRP systems are equal—know your spin, know your outcomes.
-
Let’s Get Down to Business: Doctors shouldn’t market alone—team up and thrive in today’s digital age.
-
Come Join Us: Turn orthobiologic knowledge into profit at BOB Live—your Monday-ready business accelerator.
Turn what you learn at TOBI into a thriving cash-based practice at BOB Live.
If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.
Today’s Research Article
Platelet-Rich Plasma Treatment With Physical Therapy in Chronic Partial Supraspinatus Tears
Ilker Ilhanli, Necip Guder, Murat Gul
Summary:
This randomized controlled study compared platelet-rich plasma (PRP) injections with standard physical therapy (PT) in 70 patients with chronic partial supraspinatus tears confirmed by MRI. Patients received either three weekly intra-articular PRP injections or 15 PT sessions over three weeks. Outcomes were tracked before treatment, immediately after treatment, and 12 months later, including pain (VAS), function (DASH questionnaire), shoulder range of motion (ROM), and clinical shoulder tests.
Both PRP and PT groups experienced significant long-term improvements in pain, ROM, and shoulder function. PT led to greater gains in shoulder motion and faster short-term pain relief, likely due to the structured exercise and nerve stimulation. However, PRP patients achieved significantly better improvements in functional disability (DASH scores), showing lasting benefits in daily activities. PRP was well tolerated, with no major side effects, making it a safe, autologous treatment option with promising potential for chronic partial supraspinatus tears.
Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):
